Psyence Biomedical Ltd. () Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

8.64 k

Shareholding (Sep 2024)

FII

23.60%

Held by 13 FIIs

DII

67.08%

Held by 9 DIIs

Promoter

0.00%

What does Psyence Biomedical Ltd. do?

22-Jun-2025

Psyence Biomedical Ltd. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, with no available revenue or profit data, a 0.00% dividend yield, and negative financial metrics. Contact details and registrar address are not provided.

Is Psyence Biomedical Ltd. technically bullish or bearish?

20-Sep-2025

As of September 8, 2025, Psyence Biomedical Ltd. is in a mildly bearish trend, with mixed indicators showing daily bearishness, weekly mild bullishness, and significant underperformance against the S&P 500, returning -68.48% year-to-date compared to the index's 12.22%.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 2 Million ()

P/E

Industry P/E

Dividend Yield

0.00%

Debt Equity

1.52

Return on Equity

-999,999.00%

Price to Book

0.30

Revenue and Profits:

Net Sales:

(Quarterly Results - Sep 2024)

Net Profit:

0 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-34.2%

6 Months

-65.29%

1 Year

-91.59%

2 Years

-99.97%

3 Years

-82.75%

4 Years

0.0%

5 Years

0.0%

Psyence Biomedical Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

Is Psyence Biomedical Ltd. technically bullish or bearish?

As of 8 September 2025, the technical trend for Psyence Biomedical Ltd. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by daily moving averages indicating a bearish trend, while the weekly MACD and OBV show mild bullishness. The RSI on a monthly basis is bullish, but the weekly RSI shows no signal. Additionally, Bollinger Bands are bullish on the weekly but mildly bearish on the monthly. In terms of returns, the stock has significantly underperformed compared to the S&P 500, with a year-to-date return of -68.48% versus the S&P 500's 12.22%, and a one-year return of -93.62% compared to 17.14% for the index....

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

-232.57%

EBIT to Interest (avg)

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

EV to EBIT

EV to EBITDA

EV to Capital Employed

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

ROE (Latest)

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bullish

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

OBV

No Trend

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Sep 2024

Shareholding Compare (%holding)

Majority shareholders

Foreign Institutions

Domestic Funds

Held in 5 Schemes (9.33%)

Foreign Institutions

Held by 13 Foreign Institutions (23.6%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2024 is 0.00% vs 0.00% in Sep 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2024 is 116.67% vs -175.00% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.20",
          "val2": "-0.60",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.30",
          "val2": "-0.30",
          "chgp": "533.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.10",
          "val2": "-0.60",
          "chgp": "116.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-3.70",
          "val2": "-2.80",
          "chgp": "-32.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.10",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "4.60",
          "val2": "-49.20",
          "chgp": "109.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.00",
          "val2": "-51.20",
          "chgp": "101.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'24 - YoY

Sep'24

Sep'23

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-1.20

-0.60

-100.00%

Interest

0.00

Exceptional Items

1.30

-0.30

533.33%

Consolidate Net Profit

0.10

-0.60

116.67%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2024 is 0.00% vs 0.00% in Sep 2023

Consolidated Net Profit

YoY Growth in quarter ended Sep 2024 is 116.67% vs -175.00% in Sep 2023

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-3.70

-2.80

-32.14%

Interest

0.00

0.10

-100.00%

Exceptional Items

4.60

-49.20

109.35%

Consolidate Net Profit

1.00

-51.20

101.95%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Consolidated Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Results

Company CV

About Psyence Biomedical Ltd.

Psyence Biomedical Ltd.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available

Psyence Biomedical Ltd.

1Day

52 Week

CASH

FII

DII

Promoter

What does Psyence Biomedical Ltd. do?

Watch in Real-Time

Is Psyence Biomedical Ltd. technically bullish or bearish?

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Is Psyence Biomedical Ltd. technically bullish or bearish?

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Sep 2024

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Sep'24 - YoY

Annual Results Snapshot (Consolidated) - Mar'25

About Psyence Biomedical Ltd.

Company Coordinates